V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001799 | 250004093 | 1.83 | 58.1 | null | null | 2017-10-20 | null | null | null | NIVOLUMAB | 101618369 |
| 250001801 | 250004095 | 1.83 | 76 | Neo-adjuvant (N) | 2017-05-02 | 2017-05-30 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101496885 |
| 250001803 | 250004097 | 1.7 | 58.1 | null | null | 2021-06-14 | null | null | null | NIVOLUMAB | 101523821 |
| 250001808 | 250004099 | 1.56 | 83 | Palliative (P) | 2017-04-11 | 2017-05-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | PEMBROLIZUMAB | 100549709 |
| 250001809 | 250004100 | 1.7 | 72.35 | Palliative (P) | 2019-10-28 | 2019-10-31 | null | 02 | N | CISPLATIN + GEMCITABINE | 101269700 |
| 250001810 | 250004101 | 1.82 | 80 | null | null | 2017-04-30 | null | null | null | CISPLATIN + GEMCITABINE | 101100262 |
| 250001813 | 250004104 | 1.71 | 69.4 | null | null | 2018-12-23 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100173262 |
| 250001818 | 250004107 | 1.7 | 50.4 | null | null | 2018-07-03 | null | null | null | CISPLATIN + GEMCITABINE | 100482655 |
| 250001821 | 250004110 | 1.49 | 70 | Palliative (P) | 2016-07-05 | 2016-07-09 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100691412 |
| 250001823 | 250004111 | 1.73 | 67.6 | Palliative (P) | 2018-09-25 | 2018-10-03 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101444578 |
| 250001826 | 250004114 | 1.67 | 0 | null | 2019-03-09 | 2019-03-24 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101424337 |
| 250001834 | 250004120 | 1.76 | null | null | null | 2019-09-30 | null | null | null | CARBOPLATIN + GEMCITABINE | 100891944 |
| 250001836 | 250004121 | 1.62 | 80.6 | null | null | 2019-11-08 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101505149 |
| 250001841 | 250004125 | 1.58 | 59.2 | null | 2017-08-09 | 2017-08-23 | CARBOPLATIN | 02 | null | ENZALUTAMIDE | 100345453 |
| 250001843 | 250004127 | null | null | null | null | 2018-07-19 | CARBOPLATIN + ETOPOSIDE | null | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101455624 |
| 250001849 | 250004132 | null | null | null | 2020-04-08 | 2020-04-11 | ATEZOLIZUMAB + BEVACIZUMAB | 01 | null | ATEZOLIZUMAB | 101786476 |
| 250001851 | 250004134 | null | null | null | null | 2016-09-12 | null | null | N | CARBOPLATIN + PEMETREXED | 100886577 |
| 250001853 | 250004135 | null | null | Palliative (P) | 2021-07-14 | 2021-07-16 | Imatinib 400mg | N | N | OLAPARIB | 101311697 |
| 250001854 | 250004136 | 1.84 | 72.1 | Palliative (P) | 2019-12-04 | 2019-12-04 | null | 02 | N | ENZALUTAMIDE | 100286887 |
| 250001857 | 250004138 | null | null | Neo-adjuvant (N) | 2019-08-12 | 2019-08-24 | CARBOPLATIN + ETOPOSIDE | 02 | null | ENZALUTAMIDE | 101186230 |
| 250001861 | 250004141 | null | null | null | 2019-06-10 | 2019-10-05 | Capecitabine | 02 | null | VINORELBINE | 100190702 |
| 250001862 | 250004142 | 1.84 | 53.7 | Palliative (P) | null | 2016-11-14 | Trial Unspecified | null | null | PACLITAXEL | 101602572 |
| 250001868 | 250004147 | 0 | 78.3 | Curative (C) | 2018-11-22 | 2018-11-27 | null | 02 | N | CABOZANTINIB | 100747307 |
| 250001873 | 250004151 | null | null | Palliative (P) | 2018-04-13 | 2018-04-27 | Trial Unspecified | 02 | null | CAPECITABINE + MITOMYCIN | 100768983 |
| 250001882 | 250004159 | null | null | Palliative (P) | 2019-12-30 | 2019-12-31 | Cisplatin + Radiotherapy | 02 | null | BACILLUS CALMETTE-GUERIN | 100280021 |
| 250001884 | 250004160 | 1.78 | null | null | 2018-08-12 | 2018-08-12 | Trial Unspecified | 02 | N | DOXORUBICIN | 101460373 |
| 250001885 | 250004161 | 1.6 | 81.3 | null | null | 2019-02-12 | Irinotecan + Modified De Gramont | null | null | LIPOSOMAL DOXORUBICIN | 100731209 |
| 250001891 | 250004166 | 1.67 | 72.4 | 03 | 2018-05-29 | 2018-05-29 | Cisplatin + Radiotherapy | 01 | N | DOXORUBICIN | 101789270 |
| 250001894 | 250004169 | null | null | Palliative (P) | 2020-01-27 | 2020-02-02 | Liposomal Doxorubicin 40mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101090158 |
| 250001898 | 250004173 | null | 54.35 | Palliative (P) | null | 2019-08-25 | null | null | null | DOCETAXEL | 100770690 |
| 250001899 | 250004174 | 1.76 | 73.2 | null | 2018-11-02 | 2019-01-18 | null | 01 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100191787 |
| 250001900 | 250004175 | 1.73 | 11.2 | Palliative (P) | 2016-04-09 | 2016-10-31 | Trametinib | 02 | null | IPILIMUMAB + NIVOLUMAB | 101805078 |
| 250001904 | 250004179 | null | null | Palliative (P) | 2021-04-12 | 2021-05-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | DOXORUBICIN + OLARATUMAB | 100638849 |
| 250001905 | 250004180 | 1.59 | 86.4 | Palliative (P) | 2019-02-01 | 2019-02-06 | CARBOPLATIN | 02 | N | CEMIPLIMAB | 101454941 |
| 250001907 | 250004181 | 1.95 | 97.2 | null | 2019-07-22 | 2019-08-01 | Carboplatin + Pemetrexed | N | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101745375 |
| 250001908 | 250004182 | 1.87 | 88.4 | Curative (C) | 2018-03-20 | 2018-08-12 | Carboplatin + Vinorelbine IV | 02 | null | CAPECITABINE + CARBOPLATIN | 100311467 |
| 250001913 | 250004187 | 1.67 | 89.9 | null | 2019-03-25 | 2019-04-17 | VIDE | 02 | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100856786 |
| 250001920 | 250004191 | 1.68 | 53.1 | Palliative (P) | 2018-10-12 | 2018-11-17 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101377502 |
| 250001926 | 250004193 | null | null | null | null | 2019-08-14 | DOXORUBICIN | null | null | DOXORUBICIN | 101529375 |
| 250001928 | 250004195 | null | null | Palliative (P) | null | 2017-08-11 | null | null | null | CARBOPLATIN + FLUOROURACIL | 101637360 |
| 250001937 | 250004199 | 1.74 | 83 | Palliative (P) | 2016-07-21 | 2016-08-07 | Etoposide IV | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 100966226 |
| 250001943 | 250004204 | null | null | null | 2016-11-02 | 2016-11-23 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 100776638 |
| 250001945 | 250004206 | null | null | null | null | 2017-10-10 | null | 02 | null | TRIAL UNSPECIFIED | 100171769 |
| 250001950 | 250004209 | 1.63 | 85.3 | null | 2019-11-11 | 2019-11-11 | Carboplatin AUC 2 - 5 | N | N | DOXORUBICIN | 100406757 |
| 250001960 | 250004216 | 1.87 | 56.6 | null | 2019-04-05 | 2019-04-14 | LIPOSOMAL DOXORUBICIN | 01 | null | FLUOROURACIL + MITOMYCIN | 101408256 |
| 250001962 | 250004217 | 1.61 | 53.75 | null | 2020-09-10 | 2020-09-25 | null | 2 | N | CETUXIMAB + CISPLATIN + FLUOROURACIL | 101532937 |
| 250001964 | 250004219 | 1.64 | null | Palliative (P) | 2019-04-19 | 2019-04-25 | null | 02 | null | DOXORUBICIN + OLARATUMAB | 101852759 |
| 250001966 | 250004221 | 1.72 | 61 | null | 2019-02-07 | 2019-02-07 | IVADo | null | null | CARBOPLATIN + PEMETREXED | 101147118 |
| 250001976 | 250004228 | 0 | 65.85 | Palliative (P) | 2019-06-28 | 2019-06-28 | Bevacizumab 7.5mg/kg | 02 | N | NIRAPARIB | 100273930 |
| 250001977 | 250004229 | 1.69 | 83 | Palliative (P) | 2019-02-14 | 2019-05-23 | Carboplatin AUC 6 - 10 | 02 | N | TRABECTEDIN | 100683059 |